References
- Ahnstedt, H., Patrizz, A., Chauhan, A., Roy-O’Reilly, M., Furr, J. W., Spychala, M. S., D’Aigle, J., Blixt, F. W., Zhu, L., Alegria, J. B. (2020). Sex differences in T cell immune responses, gut permeability and outcome after ischemic stroke in aged mice. Brain, Behav. Immun., 87, 556–567. DOI: 10.1016/j.bbi.2020.02.001.
- Al-Ayadhi, L., Zayed, N., Bhat, R. S., Moubayed, N. M. S., Al-Muammar, M. N., El-Ansary, A. (2021). The use of biomarkers associated with leaky gut as a diagnostic tool for early intervention in autism spectrum disorder: A systematic review. Gut Pathogens, 13 (1), 54. https://doi.org/10.1186/s13099-021-00448-y.
- Binienda, A., Twardowska, A., Makaro, A., Salaga, M. (2020). Dietary carbohydrates and lipids in the pathogenesis of leaky gut syndrome: An overview. Int. J. Mol. Sci., 21 (21), 8368. DOI: 10.3390/ijms21218368.
- Cano-Ortiz, A., Laborda-Illanes, A., Plaza-Andrades, I., Membrillo del Pozo, A., Villarrubia Cuadrado, A., Rodríguez Calvo de Mora, M., Leiva-Gea, I., Sanchez-Alcoholado, L., Queipo-Ortuño, M. I. (2020). The connection between the gut microbiome, systemic inflammation, gut permeability, and FOXP3 expression in patients with primary Sjögren’s syndrome. Int. J. Mol. Sci., 21 (22), 8733. DOI: 10.3390/ijms21228733.
- Cayres, L. C. de F., de Salis, L. V. V., Rodrigues, G. S. P., Lengert, A. van H., Biondi, A. P. C., Sargentini, L. D. B., Brisotti, J. L., Gomes, E., de Oliveira, G. L. V. (2021). Detection of alterations in the gut microbiota and intestinal permeability in patients with Hashimoto thyroiditis. Frontiers Immunol., 12, 579140. DOI: 10.3389/fimmu.2021.579140.
- Di Vincenzo, F., Del Gaudio, A., Petito, V., Lopetuso, L. R., Scaldaferri, F. (2024). Gut microbiota, intestinal permeability, and systemic inflammation: A narrative review. Intern. Emerg. Med., 19 (2), 275–293. https://doi.org/10.1007/s11739-023-03374-w.
- Fang, J., Yu, C.-H., Li, X.-J., Yao, J.-M., Fang, Z.-Y., Yoon, S.-H., Yu, W.-Y. (2022). Gut dysbiosis in nonalcoholic fatty liver disease: Pathogenesis, diagnosis, and therapeutic implications. Frontiers Cell. Infect. Microbiol., 12, 997018. DOI: 10.3389/fcimb.2022.997018.
- Feng, Y.-K., Wu, Q.-L., Peng, Y.-W., Liang, F.-Y., You, H.-J., Feng, Y.-W., Li, G., Li, X.-J., Liu, S.-H., Li, Y.-C., Zhang, Y., Pei, Z. (2020). Oral P. gingivalis impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice. J. Neuroinflamm., 17 (1), 347. https://doi.org/10.1186/s12974-020-02027-5.
- Fianchi, F., Liguori, A., Gasbarrini, A., Grieco, A., Miele, L. (2021). Nonalcoholic fatty liver disease (NAFLD) as a model of the gut–liver axis interaction: From pathophysiology to potential target of treatment for personalized therapy. Int. J. Mol. Sci., 22 (12), 6485. DOI: 10.3390/ijms22126485.
- Gan, J., Nazarian, S., Teare, J., Darzi, A., Ashrafian, H., Thompson, A. J. (2022). A case for improved assessment of gut permeability: A meta-analysis quantifying the lactulose: mannitol ratio in coeliac and Crohn’s disease. BMC Gastroenterol., 22 (1), 16. https://doi.org/10.1186/s12876-021-02082-z.
- Giron, L. B., Dweep, H., Yin, X., Wang, H., Damra, M., Goldman, A. R., Gorman, N., Palmer, C. S., Tang, H.-Y., Shaikh, M. W. (2021). Plasma markers of disrupted gut permeability in severe COVID-19 patients. Frontiers Immunol., 12, 686240. DOI: 10.3389/fimmu.2021.686240. Erratum in: Front Immunol. 2021 Oct 04;12:779064. DOI: 10.3389/fimmu.2021.779064.
- Hrncir, T., Hrncirova, L., Kverka, M., Hromadka, R., Machova, V., Trckova, E., Kostovcikova, K., Kralickova, P., Krejsek, J., Tlaskalova-Hogenova, H. (2021). Gut microbiota and NAFLD: Pathogenetic mechanisms, microbiota signatures, and therapeutic interventions. Microorganisms, 9 (5), 957. DOI: 10.3390/microorganisms9050957.
- Huang, J. G., Tanpowpong, P. (2023). Pediatric gastrointestinal endoscopy in the Asian-Pacific region: Recent advances in diagnostic and therapeutic techniques. World J. Gastroenterol., 29 (18), 2717. DOI: 10.3748/wjg.v29.i18.2717.
- Iordache, M. M., Tocia, C., Aschie, M., Dumitru, A., Manea, M., Cozaru, G. C., Petcu, L., Vlad, S. E., Dumitru, E., Chisoi, A. (2022). Intestinal permeability and depression in patients with inflammatory bowel disease. J. Clin. Med., 11 (17), 5121. DOI: 10.3390/jcm11175121.
- Ishida, I., Ogura, J., Aizawa, E., Ota, M., Hidese, S., Yomogida, Y., Matsuo, J., Yoshida, S., Kunugi, H. (2022). Gut permeability and its clinical relevance in schizophrenia. Neuropsychopharmacol. Rep., 42 (1), 70–76. https://doi.org/10.1002/npr2.12227.
- Isnard, S., Lin, J., Bu, S., Fombuena, B., Royston, L., Routy, J.-P. (2021). Gut leakage of fungal?related products: Turning up the heat for HIV infection. Frontiers Immunol., 12, 656414. https://doi.org/10.3389/fimmu.2021.656414.
- Khoshbin, K., Khanna, L., Maselli, D., Atieh, J., Breen-Lyles, M., Arndt, K., Rhoten, D., Dyer, R. B., Singh, R. J., Nayar, S. (2021). Development and validation of test for “leaky gut” small intestinal and colonic permeability using sugars in healthy adults. Gastroenterology, 161 (2), 463–475. DOI: 10.1053/j.gastro.2021.04.020.
- Kim, D. H., Krishna, S. G., Coronel, E., Kröner, P. T., Wolfsen, H. C., Wallace, M. B., Corral, J. E. (2022). Confocal laser endomicroscopy in the diagnosis of biliary and pancreatic disorders: A systematic analysis. Clin. Endosc., 55 (2), 197–207. DOI: 10.5946/ce.2021.079.
- König, R. S., Albrich, W. C., Kahlert, C. R., Bahr, L. S., Löber, U., Vernazza, P., Scheibenbogen, C., Forslund, S. K. (2022). The gut microbiome in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). Frontiers Immunol., 12, 628741. DOI: 10.3389/fimmu.2022.878196.
- Lucidi, L., Pettorruso, M., Vellante, F., Di Carlo, F., Ceci, F., Santovito, M. C., Di Muzio, I., Fornaro, M., Ventriglio, A., Tomasetti, C. (2021). Gut microbiota and bipolar disorder: An overview on a novel biomarker for diagnosis and treatment. Int. J. Mol. Sci., 22 (7), 3723. DOI: 10.3390/ijms22073723.
- Malesza, I. J., Bartkowiak-Wieczorek, J., Winkler-Galicki, J., Nowicka, A., Dzięciołowska, D., Błaszczyk, M., Gajniak, P., Słowińska, K., Niepolski, L., Walkowiak, J., Mądry, E. (2022). The dark side of iron: The relationship between iron, inflammation and gut microbiota in selected diseases associated with iron deficiency anaemia: A narrative review. Nutrients, 14 (17), 3478. DOI: 10.3390/nu14173478.
- Martín-Mateos, R., Albillos, A. (2021). The role of the gut-liver axis in metabolic dysfunction-associated fatty liver disease. Frontiers Immunol., 12, 660179. DOI: 10.3389/fimmu.2021.660179.
- Muntjewerff, E. M., Tang, K., Lutter, L., Christoffersson, G., Nicolasen, M. J. T., Gao, H., Katkar, G. D., Das, S., Ter Beest, M., Ying, W., Ghosh, P., El Aidy, S., Oldenburg, B., Van Den Bogaart, G., Mahata, S. K. (2021). Chromogranin A regulates gut permeability via the antagonistic actions of its proteolytic peptides. Acta Physiologica, 232 (2), e13655. https://doi.org/10.1111/apha.13655.
- Ouyang, J., Lin, J., Isnard, S., Fombuena, B., Peng, X., Marette, A., Routy, B., Messaoudene, M., Chen, Y., Routy, J.-P. (2020). The bacterium Akkermansia muciniphila: A sentinel for gut permeability and its relevance to HIV-related inflammation. Frontiers Immunol., 11, 645. DOI: 10.3389/fimmu.2020.00645.
- Pohl, K., Moodley, P., Dhanda, A. (2022). The effect of increasing intestinal short-chain fatty acid concentration on gut permeability and liver injury in the context of liver disease: A systematic review. J. Gastroenterol. Hepatol., 37 (8), 1498–1506. https://doi.org/10.1111/jgh.15899.
- Rodina, J., Derovs, A. (2022). Establishing the cut-offs of leaky gut syndrome diagnostic: Where are we now? Proc. Latvian Acad. Sci., Section B, 76 (5–6), 569–577. DOI: https://doi.org/10.2478/prolas-2022-0089.
- Safadi, J. M., Quinton, A. M., Lennox, B. R., Burnet, P. W., Minichino, A. (2022). Gut dysbiosis in severe mental illness and chronic fatigue: A novel trans-diagnostic construct? A systematic review and meta-analysis. Mol. Psych., 27 (1), 141–153. DOI: 10.1038/s41380-021-01032-1.
- Sánchez-Alcoholado, L., Ordóñez, R., Otero, A., Plaza-Andrade, I., Laborda-Illanes, A., Medina, J. A., Ramos-Molina, B., Gómez-Millán, J., Queipo-Ortuño, M. I. (2020). Gut microbiota-mediated inflammation and gut permeability in patients with obesity and colorectal cancer. Int. J. Mol. Sci., 21 (18), 6782. DOI: 3390/ijms21186782.
- Schoultz, I., Keita, Å. V. (2020). The intestinal barrier and current techniques for the assessment of gut permeability. Cells, 9 (8), 1909. DOI: 10.3390/cells9081909.
- Schwabe, R. F., Greten, T. F. (2020). Gut microbiome in HCC: Mechanisms, diagnosis, and therapy. J. Hepatol., 72 (2), 230–238. DOI: 10.1016/j.jhep.2019.08.016.
- Seethaler, B., Basrai, M., Neyrinck, A. M., Nazare, J.-A., Walter, J., Delzenne, N. M., Bischoff, S. C. (2021). Biomarkers for assessment of intestinal permeability in clinical practice. Amer. J. Physiol.-Gastrointest. Liver Physiol., 321 (1), G11–G17. https://doi.org/10.1152/ajpgi.00113.2021.
- Shen, L. (2020). Gut, oral, and nasal microbiota and Parkinson’s disease. Microbial Cell Factories, 19 (1), 50. https://doi.org/10.1186/s12934-020-01313-4.
- Solitano, V., D’Amico, F., Allocca, M., Fiorino, G., Zilli, A., Loy, L., Gilardi, D., Radice, S., Correale, C., Danese, S. (2021). Rediscovering histology: What is new in endoscopy for inflammatory bowel disease? Ther. Adv. Gastroenterol., 14, 17562848211005692. DOI: 10.1177/17562848211005692.
- Stadlbauer, V., Engertsberger, L., Komarova, I., Feldbacher, N., Leber, B., Pichler, G., Fink, N., Scarpatetti, M., Schippinger, W., Schmidt, R., Horvath, A. (2020). Dysbiosis, gut barrier dysfunction and inflammation in dementia: A pilot study. BMC Geriatrics, 20 (1), 248. https://doi.org/10.1186/s12877-020-01644-2.
- Stiegeler, S., Mercurio, K., Iancu, M. A., Corr, S. C. (2021). The impact of microRNAs during inflammatory bowel disease: Effects on the mucus layer and intercellular junctions for gut permeability. Cells, 10 (12), 3358. DOI: 10.3390/cells10123358.
- Tracy, M. S., Yasuda, J. L., Rufo, P. A. (2020). Protein-losing enteropathy in the setting of iron deficiency anemia: A case series. JPGN Rep., 1 (2):e009. DOI: 10.1097/PG9.0000000000000009.
- Turpin, W., Lee, S.-H., Garay, J. A. R., Madsen, K. L., Meddings, J. B., Bedrani, L., Power, N., Espin-Garcia, O., Xu, W., Smith, M. I. (2020). Increased intestinal permeability is associated with later development of Crohn’s disease. Gastroenterology, 159 (6), 2092–2100. DOI: 10.1053/j.gastro.2020.08.005.
- Vanuytsel, T., Tack, J., Farre, R. (2021). The role of intestinal permeability in gastrointestinal disorders and current methods of evaluation. Frontiers Nutr., 8, 717925. DOI: 10.3389/fnut.2021.717925.
- Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., Pascale, A. (2022). The interplay between gut microbiota and Parkinson’s disease: Implications on diagnosis and treatment. Int. J. Mol. Sci., 23 (20), 12289. DOI: 10.3390/ijms232012289.
- Zhan, Y., Al-Nusaif, M., Ding, C., Zhao, L., Dong, C. (2023). The potential of the gut microbiome for identifying Alzheimer’s disease diagnostic biomarkers and future therapies. Frontiers Neurosci., 17, 1130730. DOI: 10.3389/fnins.2023.1130730.
- Zhuge, A., Li, S., Lou, P., Wu, W., Wang, K., Yuan, Y., Xia, J., Li, B., Li, L. (2022). Longitudinal 16S rRNA sequencing reveals relationships among alterations of gut microbiota and nonalcoholic fatty liver disease progression in mice. Microbiol. Spectrum, 10 (3), e00047-22. https://doi.org/10.1128/spectrum.00047-22.